These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12487061)

  • 21. Selectively replicating adenoviruses for oncolytic therapy.
    Yoon TK; Shichinohe T; Laquerre S; Kasahara N
    Curr Cancer Drug Targets; 2001 Aug; 1(2):85-107. PubMed ID: 12188883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncolytic biotherapy: a novel therapeutic plafform.
    Hawkins LK; Lemoine NR; Kirn D
    Lancet Oncol; 2002 Jan; 3(1):17-26. PubMed ID: 11905600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance.
    Schirrmacher V
    Expert Opin Biol Ther; 2015; 15(12):1757-71. PubMed ID: 26436571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in adenovirus-mediated p53 cancer gene therapy.
    Tazawa H; Kagawa S; Fujiwara T
    Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy.
    Hakkarainen T; Hemminki A; Curiel DT; Wahlfors J
    Int J Mol Med; 2006 Oct; 18(4):751-9. PubMed ID: 16964432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy.
    Reale A; Messa L; Vitiello A; Loregian A; Palù G
    J Cell Physiol; 2017 Oct; 232(10):2641-2648. PubMed ID: 27859242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic viruses and cancer therapy.
    Norman KL; Farassati F; Lee PW
    Cytokine Growth Factor Rev; 2001; 12(2-3):271-82. PubMed ID: 11325607
    [No Abstract]   [Full Text] [Related]  

  • 28. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication-selective oncolytic viruses in the treatment of cancer.
    Everts B; van der Poel HG
    Cancer Gene Ther; 2005 Feb; 12(2):141-61. PubMed ID: 15472714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of viral thymidine kinase gene expression by replicating oncolytic adenovirus and prediction of therapeutic efficacy.
    Kim EJ; Yoo JY; Choi YH; Ahn KJ; Lee JD; Yun CO; Yun M
    Yonsei Med J; 2008 Oct; 49(5):811-8. PubMed ID: 18972602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-generation oncolytic vaccinia vectors.
    Thorne SH
    Methods Mol Biol; 2012; 797():205-15. PubMed ID: 21948478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccinia virus and oncolytic virotherapy of cancer.
    Thorne SH; Hwang TH; Kirn DH
    Curr Opin Mol Ther; 2005 Aug; 7(4):359-65. PubMed ID: 16121702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy.
    Rojas JJ; Sampath P; Hou W; Thorne SH
    Clin Cancer Res; 2015 Dec; 21(24):5543-51. PubMed ID: 26187615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oncolytic virotherapy: new strategies in oncology].
    Fábián Z
    Orv Hetil; 2007 Oct; 148(43):2019-26. PubMed ID: 17947194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans.
    Cerullo V; Koski A; Vähä-Koskela M; Hemminki A
    Adv Cancer Res; 2012; 115():265-318. PubMed ID: 23021247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer gene therapy.
    Steiner MS; Gingrich JR; Chauhan RD
    Surg Oncol Clin N Am; 2002 Jul; 11(3):607-20. PubMed ID: 12487058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy.
    Durham NM; Mulgrew K; McGlinchey K; Monks NR; Ji H; Herbst R; Suzich J; Hammond SA; Kelly EJ
    Mol Ther; 2017 Aug; 25(8):1917-1932. PubMed ID: 28578991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model.
    Li X; Wang P; Li H; Du X; Liu M; Huang Q; Wang Y; Wang S
    Clin Cancer Res; 2017 Jan; 23(1):239-249. PubMed ID: 27435398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.
    Hermiston TW; Kuhn I
    Cancer Gene Ther; 2002 Dec; 9(12):1022-35. PubMed ID: 12522441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.